| 000 | 01640 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511192718.0 | ||
| 264 | 0 | _c19920528 | |
| 008 | 199205s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19920515)69:10<2583::aid-cncr2820691031>3.0.co;2-i _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTiberghien, P | |
| 245 | 0 | 0 |
_aInterleukin-2-induced increase of a monoclonal B-cell lymphocytosis. A novel in vivo interleukin-2 effect? _h[electronic resource] |
| 260 |
_bCancer _cMay 1992 |
||
| 300 |
_a2583-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInterleukin-2 _xtherapeutic use |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xgenetics |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
| 650 | 0 | 4 |
_aLymphocytosis _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Interleukin-2 _xbiosynthesis |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 700 | 1 | _aRacadot, E | |
| 700 | 1 | _aDeschaseaux, M L | |
| 700 | 1 | _aDelain, M | |
| 700 | 1 | _aVoillat, L | |
| 700 | 1 | _aBillot, M | |
| 700 | 1 | _aFlesch, M | |
| 700 | 1 | _aRozenbaum, A | |
| 700 | 1 | _aBrandely, M | |
| 700 | 1 | _aCahn, J Y | |
| 773 | 0 |
_tCancer _gvol. 69 _gno. 10 _gp. 2583-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19920515)69:10<2583::aid-cncr2820691031>3.0.co;2-i _zAvailable from publisher's website |
| 999 |
_c1574664 _d1574664 |
||